Radioactive 125I Seed Implantation for Treatment Multiple Bone Metastases by Co-axial Needle Technique in CT Guided
Xuequan Huang,Jiuquan Zhang
DOI: https://doi.org/10.1016/j.brachy.2011.02.136
IF: 2.441
2011-01-01
Brachytherapy
Abstract:Purpose: To investigate the clinical value of CT guided radioactive seed 125I implantation in treating bone metastasis.Materials and Methods: 41 Patients(male 23, female 18, median age 49.8) with multiple bone metastasis performed CT-guided radioactive seed 125I implantation were recruited in this investigation. Among them, 9 with adenocarcinoma of lung, 6 with squamous cell carcinoma of lung, 4 renal clear-cell carcinoma, 5 with hepatocellular carcinoma, colon carcinoma respectively, 4 carcinoma of prostate respectively, 3 with breast carcinoma, 2 with pancreatic cancer, 1 with osteosarcoma, leiomyosarcoma, malignant schwannoma, respectively. All patients totally had 167 metastatic lesions, every one of them has one or more painful sites. Under CT guidance, 125I seeds were implanted into bone metastasis by co-axial needle technique according to TPS, the minimum peripheral doses (mPD) was110 – 160 Gy. The visual analogue scale(VAS)were used to assess bone pain and the imaging of lesion areas to assess the treatment response.Results: In 41 cases, complete pain relief was seen in 27 cases, partial relief in 9 cases and no change in 5 cases with an effective rate of 87.8%. After operation 2 months, 158/167 (94.6%) lesions were no change(NC) and local control(LC), 9/167 (5.4%) lesions progress (PD). Followup in every 3 months until patient died or missing followup. Local control rates for 1 year, 2 years and 3 years were 90.4%, 74.3%, 59.9%.Conclusions: CT guided radioactive seed 125I implantation procedure has good clinical effects in treating bone metastasis with minimal invasive and few complications, it may be appropriate for treating multiple bone metastasis. Purpose: To investigate the clinical value of CT guided radioactive seed 125I implantation in treating bone metastasis. Materials and Methods: 41 Patients(male 23, female 18, median age 49.8) with multiple bone metastasis performed CT-guided radioactive seed 125I implantation were recruited in this investigation. Among them, 9 with adenocarcinoma of lung, 6 with squamous cell carcinoma of lung, 4 renal clear-cell carcinoma, 5 with hepatocellular carcinoma, colon carcinoma respectively, 4 carcinoma of prostate respectively, 3 with breast carcinoma, 2 with pancreatic cancer, 1 with osteosarcoma, leiomyosarcoma, malignant schwannoma, respectively. All patients totally had 167 metastatic lesions, every one of them has one or more painful sites. Under CT guidance, 125I seeds were implanted into bone metastasis by co-axial needle technique according to TPS, the minimum peripheral doses (mPD) was110 – 160 Gy. The visual analogue scale(VAS)were used to assess bone pain and the imaging of lesion areas to assess the treatment response. Results: In 41 cases, complete pain relief was seen in 27 cases, partial relief in 9 cases and no change in 5 cases with an effective rate of 87.8%. After operation 2 months, 158/167 (94.6%) lesions were no change(NC) and local control(LC), 9/167 (5.4%) lesions progress (PD). Followup in every 3 months until patient died or missing followup. Local control rates for 1 year, 2 years and 3 years were 90.4%, 74.3%, 59.9%. Conclusions: CT guided radioactive seed 125I implantation procedure has good clinical effects in treating bone metastasis with minimal invasive and few complications, it may be appropriate for treating multiple bone metastasis.